Cargando…
Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations
Cases of neurofibromatosis type 1 (NF1)-associated medullary thyroid carcinoma (MTC) or C-cell hyperplasia are rarely associated with other endocrine tumors or cases with a multiple endocrine neoplasia type 2. In these patients, mutations were detected in the NF1 gene but no mutations were detected...
Autores principales: | Demir Gündoğan, Begümhan, Sağcan, Fatih, Tuğ Bozdoğan, Sevcan, Balcı, Yüksel, Tuncel Daloğlu, Ferah, Çıtak, Elvan Cağlar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388045/ https://www.ncbi.nlm.nih.gov/pubmed/32702947 http://dx.doi.org/10.4274/jcrpe.galenos.2020.2020.0051 |
Ejemplares similares
-
Bone densitometry measurements in children with neurofibromatosis Type 1 using quantitative computed tomography
por: Tezol, Ozlem, et al.
Publicado: (2021) -
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012) -
Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012) -
Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
por: Kumarasamy, Vishnu Muthuraj, et al.
Publicado: (2015) -
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011)